HP
Helix Pharma
Pharma & Life Sciences

A global pharma cuts MLR review cycles 64% with an evidence-grounded, regulator-defensible agent stack across 14 markets.

↓ 64%
Median MLR cycle time
2.6×
Reviewer throughput
0
Audit findings on AI-assisted reviews
The challenge

Helix's MLR review was the bottleneck for promotional launches across 14 markets.

The solution

An MLR pre-review agent stack: claims extraction identifies promotional claims, reference matching links each to approved sources, a regulatory-reasoning agent flags risk against country-specific guidance (FDA, EMA, PMDA), and a reviewer-assist UI delivers a triaged, pre-annotated piece to the MLR team.

"Launches are no longer paced by MLR. The audit trail is cleaner than humans alone."

Dr. Hannes Müller, Head of Global MLR Operations, Helix Pharma
More stories

Ready to operationalize your agents?

Talk to our team about a pilot on Synaptix Cloud or on-prem.